Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Author Archives: admin

You are here:
  1. Home
  2. Article author admin

Disclosure regarding Rameda acquiring exclusive rights for the distribution and marketing of “Physiomer” in Egypt

Regulatory DisclosuresBy adminDecember 20, 2022

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminDecember 14, 2022
Details

BOD Meeting Minutes on 14 December 2022

Board and Shareholders ActionsBy adminDecember 14, 2022
Details

ESG 3Q22 Presentation

ESG PresentationsBy adminNovember 30, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminNovember 28, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminNovember 20, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminNovember 17, 2022
Details

9M2022 Investor Presentation

By adminNovember 16, 2022

Rameda Reports its 3Q22 Results

Corporate NewsBy adminNovember 15, 2022
Details

Consolidated financial statements for the period ended 30 September 2022

Consolidated Financial Statements resultsBy adminNovember 15, 2022
←1
234567
…89101112…
131415161718192021222324252627282930313233343536
37→

All Rights Reserved © 2024

Go to Top